Pentabromopseudilin (PBrP) is a TGF-β Inhibitor for Cancer Research
In this article, we introduce a specific inhibitor of transforming growth factor-β (TGF-β) -- PBrP. It suppresses TGF-β-induced cellular responsiveness by displacing type II TGF-β receptor (TβRII) from the plasma…